Chimeric Antigen Receptor-T Cell (CAR-T Cell) Therapy in Advanced Renal Cell Carcinoma
Brian Mark Churchill, Pallavi Patri, Jula K. Inrig, Anju Gopan, Ekaterina Vorozheikina, Luis Mendoza, Lara Kristina Donato, Ruma Pal Ghosh
International Research Journal of Oncology · pp. 127–135 · Published 17 May 2021
Abstract
With introduction of immunotherapy, the treatment of advanced renal cell carcinoma has undergone a substantial change. Immunotherapeutic agents including nivolumab, ipilimumab, pembrolizumab, have been introduced and approved for therapy of this life-threatening malignancy. Chimeric antigen receptor- T cells produced using adoptive cell transfer genetic engineering technology, have shown significant benefits over previous immunotherapies, but their toxicity profile needs to be carefully weighed. While they have shown significant benefit in hematological malignancies, their role in solid tumors has shown mixed results. Several clinical trials are ongoing to evaluate their safety and efficacy in several malignancies, including advanced renal cell carcinoma. This paper reviews in brief the immunotherapy and CAR-T cell therapy in renal cell carcinoma.
Cited by 0
No indexed citations yet.
Related research
- Accessibility and Inclusivity of Chimeric Antigen Receptor T-cell Immunotherapy in Treating Hematological Malignancies — shares topic coverage
- The Dysregulation of Cyclin Dependent Kinase Regulators Role in SV40 Related Renal Cell Carcinoma — shares topic coverage
- Intradural Spinal Metastasis from Renal Cell Carcinoma: A Rare Entity — shares topic coverage
- Synchronous Metastasis of Renal Cell Carcinoma Presenting as a Primary Breast Tumor: A Rare Case Report — shares topic coverage
- Lumbar Vertebra Collapse- First Manifestation of Renal Cell Carcinoma: A Case Report — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.